What is Revena?
Revena is a healthtech company founded by Diogo Freitas and Mateus Noronha, specializing in the development of AI agents designed to automate the generation of medical bills from clinical records and payer rules. The platform seamlessly integrates with hospitals’ electronic medical record systems. By leveraging generative AI, Revena interprets complex clinical histories and intricate insurance contracts to automatically produce compliant medical bills. The company currently operates with hospitals in Brazil, facilitating deployments that enhance operational efficiency and streamline billing procedures within healthcare facilities.
How much funding has Revena raised?
Revena has raised a total of $9M across 2 funding rounds:
Angel/Pre-Seed
$1M
Seed
$8M
Angel/Pre-Seed (2024): $1M, investors not publicly disclosed
Seed (2026): $8M led by Canary, Flourish, and Caravela Capital
Key Investors in Revena
Canary
Canary is a venture capital firm that provides the first round of funding, seed or Series A, to tech companies operating in Brazil. They act as an entrepreneur-friendly, well-connected, and hands-off partner.
Flourish
Flourish Ventures is an early-stage global venture capital firm investing in fintech founders, focusing on mission-driven entrepreneurs and fair financial systems. They offer development workshops and personalized support.
Caravela Capital
Caravela Capital is a Brazilian venture capital firm that invests in early-stage companies across Latin America, providing capital and resources for growth to innovative startups.
What's next for Revena?
With the recent infusion of major strategic investment, Revena is poised for significant expansion and further development of its AI-driven medical billing solutions. This capital injection, part of its $9M total funding, suggests a move towards scaling operations, potentially expanding its market reach beyond Brazil, and enhancing its AI capabilities. The company's focus on integrating with EMR systems and ensuring billing compliance positions it as a key player in the healthtech sector, aiming to address critical inefficiencies in healthcare revenue cycles.
See full Revena company page
